Papers 2

1. Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis
   Alton EW et al., Thorax. 2017 Feb;72(2):137-147. doi: 10.1136/thoraxjnl-2016-208406.
2. A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis.
   Alton EW et al., Efficacy and Mechanism Evaluation (2016) Volume: 3 Issue: 5

Abstracts 1

1. Moving lentiviral-based gene therapy into a first-in-man CF trial.
   Griesenbach U et al.,The North American Cystic Fibrosis Conference (2015)